TrialJAMA oncology2021

Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial.

Andrew J Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.